ARTICLE | Company News
AdAlta, XL-protein deal
November 11, 2016 7:41 PM UTC
AdAlta and XL-protein partnered to develop and commercialize a long-acting version of AdAlta’s AD-114 to treat idiopathic pulmonary fibrosis (IPF). The partners will use XL-protein’s PASylation techno...
BCIQ Target Profiles